One of our monoclonal antibodies against the heavy chain of bovine kinesin (H2) also recognized the heavy chain of squid kinesin. The immunofluorescence pattern of H2 in axoplasm was similar to that seen in mammalian cells with antibodies specific for kinesin light and heavy chains, indicating that squid kinesin is also concentrated on membranebounded organeiles. Although kinesin is assumed to be a motor for translocation of membrane-bounded organelles in fast axonal transport, direct evidence has been lacking. Perfusion of axoplasm with purified H2 at 0.1-0.4 mg/ml resulted in a profound inhibition of both the rates and number of organelles moving in anterograde and retrograde directions in the interior of the axoplasm, and comparable inhibition was noted in bidirectional movement along individual microtubules at the periphery. Maximal inhibition developed over 30-60 min. Perfusion with higher concentrations of H2 (>1 mg of IgG per ml) were less effective, whereas perfusion with 0.04 mg of H2 per ml resulted in minimal inhibition. Movement ofmembranebounded organelles after perfusion with comparable levels of irrelevant mouse IgG (0.04 to >1 mg/ml) were not distinguishable from perfusion with buffer controls. Inhibition offast axonal transport by an antibody specific for kinesin provides direct evidence that kinesin is involved in the translocation of membrane-bounded organelles in axons. Moreover, the inhibition of bidirectional axonal transport by H2 raises the possibility that kinesin may play some role in both anterograde and retrograde axonal transport.
Since discovery of the mechanochemical ATPase kinesin (1, 2) , many different physiological functions have been suggested. While kinesins have been proposed to mediate translocation of membrane-bounded organelles (MBOs), cytoskeletal and chromosome movements, secretion, and reorganization of the endoplasmic reticulum (3), these suggestions have remained at the level of speculation. The ability of kinesin to mediate gliding of microtubules (MTs) across a glass coverslip (2, 4) indicated that kinesin could do work, but the physiological correlate of this phenomenon was uncertain. The most widely accepted role for kinesin has been as the motor for fast anterograde axonal transport. However, despite intensive study in a number of laboratories, the evidence for involvement of kinesin in fast transport or in other forms of in vivo motility has remained indirect and correlative.
Direct evidence for involvement of kinesin in cellular motility could take several forms. One obvious approach would be reconstitution of the physiological process with well-characterized constituents. For MBO translocation along MTs, suitable purified constituents would consist of MTs assembled without MT-associated proteins, a wellcharacterized fraction of MBOs, and highly purified kinesin. Alternatively, direct evidence could be provided by suitable immunochemical probes that inhibit kinesin function. Appropriate antibodies could interfere with kinesin function by inhibiting ATPase activity, binding of kinesin to either MTs or MBOs, or conformational changes associated with translocation. A similar approach utilizing myosin-specific antibodies provided direct evidence for involvement of myosin in cell morphology, locomotion, and cytokinesis, but not chromosome movement (5) (6) (7) .
While kinesin has been purified to >90% homogeneity (8) and shown to be a MT-stimulated ATPase (1, 8, 9) , the goal of recombining kinesin with MBOs remains elusive. Recombination studies have proved to be technically difficult, and little has been known about interactions of kinesin with MBOs. Surprisingly, direct evidence that kinesin is associated with MBOs in vivo only recently has been obtained (10) .
Initially, evidence for kinesin association with MBOs was inferred from observations that the nonhydrolyzable analogue of ATP, 5'-adenylyl imidodiphosphate (p[NH]ppA; also called AMP-PNP), caused both vesicles (11) and kinesin (1, 2) to bind to MTs. Direct evidence for kinesin association with MBOs has now been obtained by an immunological approach using our library of monoclonal antibodies to heavy and light chains of bovine kinesin (10) . Unlike previously described antibodies to the kinesin heavy chain (12) (13) (14) (15) (16) , which provided conflicting images for subcellular localization of kinesin, immunofluorescence studies with our library of five monoclonal antibodies established kinesin association with MBOs. All five antibodies (to heavy and light chains) produce similar, detergent-sensitive, punctate immunofluorescence patterns identified as MBOs in a variety of vertebrate cell types (10) . Using the same antibodies, we have shown kinesin to copurify with MBOs (unpublished observations).
Isolated axoplasm from squid giant axons has proved to be a powerful model for study of the molecular mechanisms of fast axonal transport (17, 18) . The absence of a plasma membrane permits introduction of defined amounts of proteins and antibodies that do not readily enter intact cells or axons, while retaining the native organization and concentration of cytoplasmic components (18) (19) (20) . One of our antibodies to bovine kinesin heavy chain (H2) crossreacted with squid kinesin heavy chain, raising the possibility that H2 could be used as a probe of both the distribution and physiological function of kinesin in isolated axoplasm. The amount of kinesin in axoplasm was determined from quantitative immunoblots with H2. Immunofluorescent studies of Abbreviations: MBO, membrane-bounded organelle; MT, microtubule; p[NH]ppA (AMP-PNP), 5'-adenylyl imidodiphosphate. 1To whom reprint requests should be addressed.
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squid axoplasm resulted in punctate patterns homologous with those seen in mammalian cells. Perfusion of H2 into axoplasm inhibited the rate and number of particles moving in fast axonal transport. Surprisingly, both anterograde and retrograde transport were inhibited to a similar extent, in contrast with in vitro evidence that kinesin is involved only in anterograde transport (15 cross-reactivity with kinesins from different sources and appeared to recognize the full complement of isoforms for bovine kinesin heavy chain (8, 10) .
The concentration of kinesin in squid axoplasm was determined by laser densitometry of quantitative immunoblots. Defined amounts of axoplasm were probed with H2 on blots that contained dilutions of bovine kinesin covering the linear range for densitometry. Quantitative immunoblots gave a kinesin concentration in squid axoplasm of =0.5 uM. By comparison, tubulin concentration in axoplasm is -4 /.M (25) , giving a molar ratio of 1:8 for kinesin to tubulin in squid axoplasm.
Immunocytochemical localization of kinesin in squid axoplasm by indirect immunofluorescence with H2 ( Fig. 2) gave a pattern similar to that seen in mammalian cells with our antibodies specific for kinesin light and heavy chains. The kinesin-positive structures form a characteristically punctate pattern ( Fig. 2A) . No specific staining was seen either with control IgG (Fig. 2B) The effects of H2 on fast axonal transport were evaluated by perfusion of axoplasm. Concentrations of H2 between 0.1 and 0.6 mg/ml resulted in a profound inhibition in the rates and number of MBOs moving in both anterograde and retrograde directions (see Table 1 and Fig. 3 ). Inhibition of bidirectional transport was comparable at the axoplasm periphery along individual MTs and in the interior of the axoplasm. In both regions, inhibition by H2 had a characteristic time course (Fig. 3 ). An initial =25% reduction in velocity was seen in the first 10 min, followed by a second 30-to 60-min phase of increasing inhibition. At 60 min and optimal antibody concentrations, velocities were typically reduced by 60-70%o. The extent and timing of inhibition were similar but not identical in the axoplasm interior and on isolated peripheral MTs; reductions in velocity became apparent somewhat later in the interior rather than on the periphery, presumably due to the time required for H2 diffusion into axoplasm (18, 20) . Inhibition was maximal by 30-60 min throughout the preparation. Optimal inhibition by H2 occurred at molar ratios of antibody/kinesin of -1-5, assuming 0.5 ,uM kinesin. Perfusion with higher H2 concentrations (7-10 ,uM IgG) were less effective at reducing rates, while perfusion with H2 < 0.3 ,uM was ineffective. No effect on fast axonal transport was seen for similar concentrations of control IgG (Table 1 and Fig. 3) .
The biochemical basis of H2 inhibition was evaluated by in vitro assay systems for MT-stimulated ATPase of kinesin and nucleotide-sensitive binding of kinesin to MTs. Molar ratios of H2 to kinesin from 1 to 5 did not inhibit the MT-stimulated ATPase (M. Wagner, S.T.B., K.K.P., and G.S.B., unpublished data), although higher molar ratios (60-to 110-fold excess of antibody) partially inhibited ATPase activity. Table 1 ).
axonal transport. Despite a substantial amount of correlative evidence, defining the role of kinesin in intracellular motility proved elusive. Moreover, the discovery of cytoplasmic dyneins (26) (27) (28) (29) complicated interpretation of pharmacological assays and in vitro studies implicating kinesin as the motor in fast axonal transport. To understand the physiological roles of kinesin, direct evidence for kinesin involvement in axonal transport or other physiological prqcesses is needed. Such direct evidence has two components-(i) kinesin must have an appropriate subcellular location and (it) molecular (biochemical, pharmacological, or immunochemical) probes specific for kinesin must inhibit the physiological activity. Antibodies specific for kinesin polypeptides have the potential to satisfy both criteria.
Our library of monoclonal antibodies (10) constitutes an important set of tools for exploring the role of kinesin in many forms'of cell motility. The specificity of these antibodies, each recognizing a unique epitope, has been demonstrated on both purified kinesin and cellular extracts. Ultrastructural localization of epitopes for these antibodies on kinesin documented specificity and provided details on the molecular architecture of kinesin (21) . Immunocytochemical studies with' the antibodies showed kinesin localized on MBOs in both neuronal and nonneuronal cells in culture (10) . Kinesin was notably absent from cytoskeletal structures, suggesting that its primary association is with MBOs. The size, distribution, and number of kinesin-positive structures in squid axoplasm (see Fig. 2 ) and other cell types are consistent with kinesin being localized on transported MBOs. Thus, kinesin has the appropriate cellular and subcellular location to be a motor for fast axonal transport.
Once reactivity of H2 with squid kinesin was demonstrated, theeffects of H2 on fast axonal transport in axoplasm could be evaluated. Perfusion of suitable concentrations of H2 into axoplasm inhibited both anterograde and retrograde axonal transport to a similar extent with a similar time course. Thus, studies with H2 satisfy both criteria for direct evidence that kinesin is involved in translocation of MBOs along MTs. Comparisons between the axoplasm periphery, where transport of MBOs can be followedvalong individual MTs, and the axoplasm interior, where axoplasmic organization was retained, were particularly instructive. (15) . Earlier suggestions were based on the fact that MT gliding mediated by kinesin was unidirectional (4, 15) . Subsequently, cytoplasmic dynein was found to produce MT gliding in the opposite direction, leading to proposals that cytoplasmic dynein was the motor for retrograde transport (27) . A number of biochemical and pharmacological differences have been noted between gliding due to kinesin (4, 15) and that due to cytoplasmic dynein (27) In summary, the role of kinesin in the intracellular transport of MBOs has been explored by using H2, an antibody specific for kinesin heavy chain. Inhibition of fast axonal transport by H2, when combined with localization of kinesin on MBOs, provides direct evidence that kinesin is involved in axonal transport of MBOs. The fact that bidirectional transport is inhibited by H2 raises the possibility that kinesin may play a role in both anterograde and retrograde axonal transport.
Note. Video sequences illustrating the effects of control IgG and H2 antibody on transport of membrane-bounded organelles are to be included in the second video supplement of "Cell Motility and the Cytoskeleton," scheduled for publication in 1989.
